Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.31M Sell
9,517
-439
-4% -$119K 0.91% 32
2025
Q4
$2.95M Sell
9,956
-351
-3% -$105K 1.15% 22
2025
Q3
$2.91M Sell
10,307
-347
-3% -$90.8K 1.22% 19
2025
Q2
$3.14M Sell
10,654
-247
-2% -$63.6K 1.47% 16
2025
Q1
$2.71M Sell
10,901
-291
-3% -$71.2K 1.34% 17
2024
Q4
$2.46M Sell
11,192
-882
-7% -$196K 1.21% 21
2024
Q3
$2.67M Buy
12,074
+45
+0.4% +$8.82K 1.34% 21
2024
Q2
$2.08M Buy
12,029
+21
+0.2% +$3.65K 1.17% 22
2024
Q1
$2.29M Buy
12,008
+21
+0.2% +$3.83K 1.33% 20
2023
Q4
$1.96M Buy
11,987
+132
+1% +$19.9K 1.26% 21
2023
Q3
$1.66M Buy
11,855
+107
+0.9% +$15.2K 1.21% 21
2023
Q2
$1.57M Buy
11,748
+524
+5% +$67.6K 1.1% 23
2023
Q1
$1.47M Buy
11,224
+446
+4% +$59.7K 1.12% 21
2022
Q4
$1.52M Buy
10,778
+831
+8% +$115K 1.21% 20
2022
Q3
$1.18M Buy
9,947
+572
+6% +$75.1K 1.03% 26
2022
Q2
$1.32M Buy
9,375
+203
+2% +$27.4K 1.12% 23
2022
Q1
$1.19M Sell
9,172
-200
-2% -$26.1K 0.82% 31
2021
Q4
$1.25M Buy
+9,372
New +$1.18M 0.84% 28

Other funds holding IBM

O'Rourke & Company's IBM Position: Q1 2026 in Review

O'Rourke & Company reduced its IBM (IBM) stake by 4.4% in Q1 2026, selling an estimated $119K and leaving 9,517 shares worth $2.31M. The position accounts for 0.91% of the portfolio, ranked #32.

O'Rourke & Company first reported a position in IBM in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.14M in Q2 2025. 3,462 funds tracked by Wall St. Rank hold IBM as of Q1 2026.

  • O'Rourke & Company held 9,517 shares of IBM worth $2.31M as of Q1 2026.
  • O'Rourke & Company sold 439 IBM shares in Q1 2026, an estimated $119K.
  • IBM made up 0.91% of O'Rourke & Company's portfolio in Q1 2026, its #32 holding.
  • O'Rourke & Company first reported a position in IBM in Q4 2021 and has held it in 18 quarters since.
  • O'Rourke & Company's IBM position peaked at $3.14M in Q2 2025.
  • 3,462 funds tracked by Wall St. Rank held IBM as of Q1 2026.

Based on O'Rourke & Company's 13F filing for Q1 2026, filed 14 May 2026.